We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXK:NYSEEndeavour Silver Corporation Analysis

Data as of 2026-08-15 - not real-time

$10.66

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Endeavour Silver Corp. trades at $10.66, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 24.5%. With RSI at 70.5 the momentum picture is overbought, alongside a bullish MACD signal. The recent range runs from support at $7.19 up to resistance at $11.02.
The shares look fair at 53.3 times earnings, though no sector average was available for comparison. Analyst price targets sit 45.4% above the current price. Revenue is growing at 139.4% on a 8.9% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 68.8%, a beta of 2.76 and a maximum drawdown of 47.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

VANCOUVER, British Columbia, Aug. 05, 2026 GLOBE NEWSWIRE -- Endeavour Silver Corp. “Endeavour” or the...Yahoo Finance14dEndeavour Silver Corp EXK Q2 2026 Earnings Call Highlights: Record Production and Revenue .A required part of this site couldn’t load.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 70.5 signals overbought conditions
  • Trading above the 200-day average of 9.61
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 70.5 signals overbought conditions
  • Trading above the 200-day average of 9.61
  • Analyst targets imply +45.4% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +45.4% versus the current price
  • Revenue growth of +139.4%
  • P/E ratio of 53.3

Key Metrics & Analysis

Financial Health

Revenue Growth139.40%
Profit Margin8.91%
P/E Ratio53.3
ROE10.58%
ROA10.13%
Debt/Equity34.84
P/B Ratio4.4
Op. Cash Flow$103.1M
Free Cash Flow$67.7M

Technical Analysis

TrendNeutral
RSI70.5
Support$7.19
Resistance$11.02
MA 20$8.71
MA 50$8.41
MA 200$9.61
MACDBullish
VolumeStable
Fear & Greed Index95.98

Valuation

Fair Value$8.04
Target Price$15.50
Upside/Downside45.40%
GradeFair
TypeGrowth

Risk Assessment

Beta2.76
Volatility68.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.